Cargando…

Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty

BACKGROUND: The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of question banks for health domains through computer adaptive testing (CAT). HYPOTHESIS: For patients with glenohumeral arthritis, (1) there would be high correlation between traditional patient-reported outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowdle, S. Blake, Glass, Natalie, Anthony, Chris A., Hettrich, Carolyn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
8
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602218/
https://www.ncbi.nlm.nih.gov/pubmed/28944248
http://dx.doi.org/10.1177/2325967117726044
_version_ 1783264538750091264
author Dowdle, S. Blake
Glass, Natalie
Anthony, Chris A.
Hettrich, Carolyn M.
author_facet Dowdle, S. Blake
Glass, Natalie
Anthony, Chris A.
Hettrich, Carolyn M.
author_sort Dowdle, S. Blake
collection PubMed
description BACKGROUND: The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of question banks for health domains through computer adaptive testing (CAT). HYPOTHESIS: For patients with glenohumeral arthritis, (1) there would be high correlation between traditional patient-reported outcome (PRO) measures and the PROMIS upper extremity item bank (PROMIS UE) and PROMIS physical function CAT (PROMIS PF CAT), and (2) PROMIS PF CAT would not demonstrate ceiling effects. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 3. METHODS: Sixty-one patients with glenohumeral osteoarthritis were included. Each patient completed the American Shoulder and Elbow Surgeons (ASES) assessment form, Marx Shoulder Activity Scale, Short Form–36 physical function scale (SF-36 PF), EuroQol 5 Dimensions (EQ-5D) questionnaire, Western Ontario Osteoarthritis Shoulder (WOOS) index, PROMIS PF CAT, and the PROMIS UE. Correlation was defined as high (>0.7), moderate (0.4-0.6), or weak (0.2-0.3). Significant floor and ceiling effects were present if more than 15% of individuals scored the lowest or highest possible total score on any PRO. RESULTS: The PROMIS PF demonstrated excellent correlation with the SF-36 PF (r = 0.81, P < .0001) and good correlation with the ASES (r = 0.62, P < .0001), EQ-5D (r = 0.64, P < .001), and WOOS index (r = 0.51, P < .01). The PROMIS PF demonstrated low correlation with the Marx scale (r = 0.29, P = .02). The PROMIS UE demonstrated good correlation with the ASES (r = 0.55, P < .0001), SF-36 (r = 0.53, P < .01), EQ-5D (r = 0.48, P < .01), and WOOS (r = 0.34, P <.01), and poor correlation with the Marx scale (r = 0.06, P = .62). There were no ceiling or floor effects observed. The mean number of items administered by the PROMIS PRO was 4. CONCLUSION: These data suggest that for a patient population with operative shoulder osteoarthritis, PROMIS UE and PROMIS PF CAT may be valid alternative PROs. Additionally, PROMIS PF CAT offers a decreased question burden with no ceiling effects.
format Online
Article
Text
id pubmed-5602218
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-56022182017-09-22 Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty Dowdle, S. Blake Glass, Natalie Anthony, Chris A. Hettrich, Carolyn M. Orthop J Sports Med 8 BACKGROUND: The Patient-Reported Outcomes Measurement Information System (PROMIS) consists of question banks for health domains through computer adaptive testing (CAT). HYPOTHESIS: For patients with glenohumeral arthritis, (1) there would be high correlation between traditional patient-reported outcome (PRO) measures and the PROMIS upper extremity item bank (PROMIS UE) and PROMIS physical function CAT (PROMIS PF CAT), and (2) PROMIS PF CAT would not demonstrate ceiling effects. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 3. METHODS: Sixty-one patients with glenohumeral osteoarthritis were included. Each patient completed the American Shoulder and Elbow Surgeons (ASES) assessment form, Marx Shoulder Activity Scale, Short Form–36 physical function scale (SF-36 PF), EuroQol 5 Dimensions (EQ-5D) questionnaire, Western Ontario Osteoarthritis Shoulder (WOOS) index, PROMIS PF CAT, and the PROMIS UE. Correlation was defined as high (>0.7), moderate (0.4-0.6), or weak (0.2-0.3). Significant floor and ceiling effects were present if more than 15% of individuals scored the lowest or highest possible total score on any PRO. RESULTS: The PROMIS PF demonstrated excellent correlation with the SF-36 PF (r = 0.81, P < .0001) and good correlation with the ASES (r = 0.62, P < .0001), EQ-5D (r = 0.64, P < .001), and WOOS index (r = 0.51, P < .01). The PROMIS PF demonstrated low correlation with the Marx scale (r = 0.29, P = .02). The PROMIS UE demonstrated good correlation with the ASES (r = 0.55, P < .0001), SF-36 (r = 0.53, P < .01), EQ-5D (r = 0.48, P < .01), and WOOS (r = 0.34, P <.01), and poor correlation with the Marx scale (r = 0.06, P = .62). There were no ceiling or floor effects observed. The mean number of items administered by the PROMIS PRO was 4. CONCLUSION: These data suggest that for a patient population with operative shoulder osteoarthritis, PROMIS UE and PROMIS PF CAT may be valid alternative PROs. Additionally, PROMIS PF CAT offers a decreased question burden with no ceiling effects. SAGE Publications 2017-09-15 /pmc/articles/PMC5602218/ /pubmed/28944248 http://dx.doi.org/10.1177/2325967117726044 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (http://www.creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle 8
Dowdle, S. Blake
Glass, Natalie
Anthony, Chris A.
Hettrich, Carolyn M.
Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title_full Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title_fullStr Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title_full_unstemmed Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title_short Use of PROMIS for Patients Undergoing Primary Total Shoulder Arthroplasty
title_sort use of promis for patients undergoing primary total shoulder arthroplasty
topic 8
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602218/
https://www.ncbi.nlm.nih.gov/pubmed/28944248
http://dx.doi.org/10.1177/2325967117726044
work_keys_str_mv AT dowdlesblake useofpromisforpatientsundergoingprimarytotalshoulderarthroplasty
AT glassnatalie useofpromisforpatientsundergoingprimarytotalshoulderarthroplasty
AT anthonychrisa useofpromisforpatientsundergoingprimarytotalshoulderarthroplasty
AT hettrichcarolynm useofpromisforpatientsundergoingprimarytotalshoulderarthroplasty